Department of Physical Therapy
Granada, Spain, 18071
NCT Number: NCT01988844
Cerebral palsy is the leading cause of physical disability among children. Manual dexterity and upper limbs functionality is limited between these children. The purpose of this study is to stablish a specific profile of school children with cerebral palsy based on the upper limbs assessment.
Looking for future studies?
Notify Me6 year–10 year
All sexes
Observational
Granada, Spain, 18071
While the rates of perinatal and infant mortality have declined toward the end of the last century,the rate of cerebral palsy has remained at 2 to 2.5 per 1,000 live births. A high percentage of children with cerebral palsy have difficulty keeping up with the handwriting demands at school. The neurological impairments in children with cerebral palsy frequently limit the functionality of these children taken in to account the upper limbs variables. It should be interesting to describe a clinical profile based on this assessment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The children with cerebral palsy were assessed. Different measures evaluating the upper limbs functionality are used.
Other names: Evaluation, Description
Time frame: baseline
This inventory assess the key functional capabilities and performance in children between six months to seven years old. Three subscales are observed: self-care, mobility and social function. It helps you to identify areas of new functional intervention. Also, it is used to identify functional deficits.
Time frame: baseline
The functionality is measured using the Abilhand-kids questionnaire. This questionnaire was designed to cover the widest range of children's manual activities including both unimanual and bimanual activities. For each question, the children and their parents were asked to provide their perceived difficulty to perform the activity on a three-level scale: impossible (0), difficult (1), or easy (2).
Time frame: baseline
Manual dexterity is measured using the 9-hole peg test. This is a brief, standardized, quantitative test of upper extremity function. Both the dominant and non-dominant hands are tested twice. The patient is seated at a table with a small container holding nine pegs. The patient picks up the nine pegs one at a time as quickly as possible, puts them in the nine holes, and, once they are in the holes, removes them again as quickly as possible one at a time, replacing them into the shallow container. The time is recorded.
Time frame: baseline
The executive function is measured using the Porteus Maze Test. It consists of a series of mazes graded in difficulty and standardized for application to children from three years old.
Time frame: baseline
The handwriting ability is measured with the Handwriting without tears method. It is used to assess memory, letter size,space and movement control.
Time frame: baseline
The range of motion in upper limbs is measured with a standard goniometer at different levels: elbow, wrist and fingers.
Time frame: baseline
The strength is evaluated using a digital dynamometer. The strength is measured in Newtons.
Universidad de Granada
Other
Manual Dexterity and Upper Limbs Functionality Assessment in School Children With Cerebral Palsy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02364856
Brain Damage, Chronic, Brain Diseases
Lille, France
View Trial DetailsNCT06667518
Brain Damage, Chronic, Brain Diseases
Lamia, Phthiotis, Greece
View Trial DetailsNCT02918890
Behavior, Brain Damage, Chronic
New York, United States
View Trial DetailsNCT03818152
Brain Damage, Chronic, Brain Diseases
Ghent, Belgium
View Trial Details